Vasoactive intestinal polypeptide modulation of lymphocyte adenylate cyclase.

Vasoactive intestinal polypeptide (VIP) was found to be a potent stimulator of lymphocyte adenylate cyclase activity. VIP-induced activation of adenylate cyclase was specific for lymphocytes among peripheral blood cells; i.e., VIP did not stimulate the adenylate cyclase activity of neutrophils, monocytes, or platelets. The VIP-induced activation of lymphocyte adenylate cyclase was time, temperature, and concentration dependent. VIP and the GTP analog, Gpp(NH)p, acted synergistically to stimulate lymphocyte adenylate cyclase; stimulation by VIP and PGE1 was additive; and VIP activation was antagonized by somatostatin. VIP-mediated activation of lymphocyte adenylate cyclase was observed in normal human T cells, B cells obtained from a patient with chronic lymphocytic leukemia, and a human T cell culture line. The Raji human B cell culture line did possess adenylate cyclase activity, but this activity was not stimulated by VIP. These results suggest that lymphocytes possess functional receptors for VIP and that this peptide may play a role in modulation of lymphocyte function.

• Publication year

  1981

• Venue

  Journal of Immunology

• Publication date

  1981-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.127.6.2551PMID 6975328
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The binding of 125I-insulin to specific receptors in IM-9 human lymphocytes. Detection of radioactivity covalently linked to receptors.

  1981cited by this paper
• Limited proteolysis eliminates guanine nucleotide inhibition of choleragen-activated adenylate cyclase. Possible basis for proteolytic stimulation of cyclic AMP production.

  1980cited by this paper
• Vasoactive intestinal polypeptide as a biochemical marker for polymorphonuclear leukocytes.

  1980cited by this paper
• Insulin receptors of cultured human lymphocytes (IM-9). Lack of receptor-mediated degradation.

  1980cited by this paper
• Hybridization of adenylate cyclase components by membrane fusion and the effect of selective digestion by trypsin.

  1980cited by this paper
• Effect of cyclic AMP and cholera toxin on the migration of rat polymorphonuclear leucocytes in boyden chambers

  1980cited by this paper
• Vasoactive intestinal polypeptide in tissues of the human female reproductive tract.

  1979cited by this paper
• Human monocyte killing of Staphylococcus aureus: modulation by agonists of cyclic adenosine 3',5'-monophosphate and cyclic guanosine 3',5'-monophosphate

  1979cited by this paper
• Hormone‐receptor‐adenylate cyclase interactions

  1979cited by this paper
• Prostaglandin E modulation of the mitogenic response of human T cells. Differential response of T-cell subpopulations.

  1979cited by this paper
• VASOACTIVE INTESTINAL POLYPEPTIDE PROMOTES CYCLIC ADENOSINE 3‘,5’‐MONO‐PHOSPHATE ACCUMULATION IN GUINEA‐PIG TRACHEA

  1978cited by this paper
• Release of vasoactive intestinal polypeptide in mast cells by histamine liberators

  1978cited by this paper
• Characterization of a vasoactive intestinal peptide-sensitive adenylate cyclase in rat intestinal epithelial cell membranes.

  1978cited by this paper
• The predominant contribution of platelets to baseline and ascorbate-stimulated increments in cyclic GMP in human mononuclear leukocyte preparations.

  1978cited by this paper
• Evidence for distinct guanine nucleotide sites in the regulation of the glucagon receptor and of adenylate cyclase activity.

  1977cited by this paper
• Regulation of prostaglandin receptors by prostaglandins and guanine nucleotides in frog erythrocytes.

  1977cited by this paper
• Effect of phagocytosis on the reduced soluble sulfhydryl content of human granulocytes.

  1977cited by this paper
• Vasoactive intestinal polypeptide in brain: localization in and release from isolated nerve terminals.

  1977cited by this paper
• Characterization of VIP‐sensitive adenylate cyclase in guinea pig brain

  1977cited by this paper
• Cyclic AMP in pancreatic acinar cells: effects of gastrointestinal hormones.

  1976cited by this paper
• Regulation of beta-adrenergic receptors by guanyl-5'-yl imidodiphosphate and other purine nucleotides.

  1976cited by this paper
• Intractable watery diarrhea, ganglioneuroblastoma, and vasoactive intestinal peptide.

  1976cited by this paper
• Interaction of porcine vasoactive intestinal peptide with dispersed pancreatic acinar cells from the guinea pig. Structural requirements for effects of vasoactive intestinal peptide and secretin on cellular adenosine 3':5'-monophosphate.

  1976cited by this paper
• Characteristics of 5'-guanylyl imidodiphosphate-activated adenylate cyclase.

  1975cited by this paper
• Elevated plasma and tissue levels of vasoactive intestinal polypeptide in the watery-diarrhea syndrome due to pancreatic, bronchogenic and other tumors.

  1975cited by this paper
• Hormone receptors, 5. Binding of glucagon and insulin to human circulating mononuclear cells in diabetes mellitus.

  1975cited by this paper
• Antibody-dependent lymphocyte mediated cytotoxicity mechanism and modulation by cyclic nucleotides.

  1975cited by this paper
• Vasoactive intestinal polypoptide: inactivation in liver and potentiation in lung of anesthetized dogs (384699).

  1975cited by this paper
• HUMORAL CONTROL OF AIRWAYS *

  1974cited by this paper
• Hemolytic plaque formation by leukocytes in vitro. Control by vasoactive hormones.

  1974cited by this paper
• Characterization of glass adherent human mononuclear cells.

  1973cited by this paper
• Characteristics of the human lymphocyte insulin receptor.

  1973cited by this paper
• Enhanced binding of neuraminidase-treated sheep erythrocytes to human T lymphocytes.

  1973cited by this paper
• Isolation from porcine-intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon.

  1972cited by this paper
• Cyclic adenosine 3',5'-monophosphate in human lymphocytes. Alterations after phytohemagglutinin stimulation.

  1971cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Genetic Disruption of VIP Signaling Alters Intestinal Microbial Structure and Immunity

  2018cites this paper
• Neuroendocrine cells derived chemokine vasoactive intestinal polypeptide (VIP) in allergic diseases.

  2017cites this paper
• Biological effects of vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide receptor 1 (VPAC1) and VPAC2 on chemotaxis and its regulation of the tumor suppressor Ikaros in leukemic T cells

  2012influential citation
• Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions

  2011cites this paper
• The Role of Glucagon-like Peptides in Experimental Type 1 Diabetes

  2010cites this paper
• VPAC and PAC receptors: From ligands to function.

  2009cites this paper
• Stimulatory and suppressive signal transduction regulates vasoactive intestinal peptide receptor-1 (VPAC-1) in primary mouse CD4 T cells.

  2008cites this paper
• Immunmodulation durch gastrointestinale Neuropeptide

  2008cites this paper
• TCR signaling and environment affect vasoactive intestinal peptide receptor-1 (VPAC-1) expression in primary mouse CD4 T cells.

  2008cites this paper
• CHAPTER 5 – Vasoactive Intestinal Peptide: An Anti-inflammatory Neuropeptide

  2007cites this paper
• The pharmacology and function of central VPAC/PAC receptors

  2007cites this paper
• Protective Role for Plasmid DNA‐Mediated VIP Gene Transfer in Non‐Obese Diabetic Mice

  2006cites this paper
• Novel concepts of neuropeptide-based drug therapy: vasoactive intestinal polypeptide and its receptors.

  2006cites this paper
• Signaling mechanisms of vasoactive intestinal peptide in inflammatory conditions.

  2006cites this paper
• Immunomodulating peptides

  2005cites this paper
• The role of tachykinins on bacterial infections.

  2004cites this paper
• The Significance of Vasoactive Intestinal Peptide in Immunomodulation

  2004influential citation
• VIP- and PACAP-mediated immunomodulation as prospective therapeutic tools.

  2003cites this paper
• Suppression of tumorigenicity in neuroblastoma cells by upregulation of human vasoactive intestinal peptide receptor type 1.

  2002cites this paper
• Vasoactive intestinal polypeptide as mediator of asthma.

  2001cites this paper
• Selective Gene Expression and Activation-Dependent Regulation of Vasoactive Intestinal Peptide Receptor Type 1 and Type 2 in Human T Cells1

  2001cites this paper
• Review Neuroendocrine and immune interactions with airway macrophages

  2000cites this paper
• Neuroendocrine and immune interactions with airway macrophages

  2000cites this paper
• Identification of Cells Responding to Vasoactive Intestinal Peptide by Measuring Intracellular Cyclic Adenosine Monophosphate in Human Colonic Mucosa

  2000cites this paper
• Neuroendocrine Immune Axis in the Intestine

  1999cites this paper
• Neuro‐immune interactions in the lung

  1999cites this paper
• Neuropeptide contents in the duodenum of non-obese diabetic mice

  1998cites this paper
• Neuroendocrine peptide hormone regulation of immunity.

  1997cites this paper
• Functional characterization and mRNA expression of pituitary adenylate cyclase activating polypeptide (PACAP) type I receptors in rat peritoneal macrophages.

  1997cites this paper
• Neuroendocrine peptide hormone regulation of immunity.

  1997cites this paper
• Characterization of VIP receptor-effector system antagonists in rat and mouse peritoneal macrophages.

  1997cites this paper
• Immune-neuro-endocrine interactions: facts and hypotheses.

  1996cites this paper
• Murine T-lymphocytes express vasoactive intestinal peptide receptor 1 (VIP-R1) mRNA.

  1996cites this paper
• Pituitary adenylate cyclase-activating polypeptide (PACAP38) modulates lymphocyte and macrophage functions: stimulation of adherence and opposite effect on mobility

  1996cites this paper
• Vasoactive intestinal peptide enhances immunoglobulin production and growth in human plasma cells via mechanisms that may involve protein kinase C.

  1996cites this paper
• Effect of calcitonin gene-related peptide and vasoactive intestinal peptide on murine CD4 and CD8 T cell proliferation.

  1996cites this paper
• Expression of vasoactive intestinal peptide binding sites in rat peritoneal macrophages is stimulated by inflammatory stimulus.

  1996cites this paper
• Characterization of VIP-and helodermin-preferring receptors on rat platelets.

  1996cites this paper
• Down‐regulation of Cytokine Expression in Murine Lymphocytes by PACAP and VIP

  1996cites this paper
• Vasoactive intestinal peptide inhibits IL-4 production in murine T cells by a post-transcriptional mechanism.

  1996cites this paper
• Vasoactive intestinal peptide regulation of granulomatous inflammation in murine Schistosomiasis mansoni.

  1996cites this paper
• The significance of vasoactive intestinal polypeptide (VIP) in immunomodulation.

  1996cites this paper
• VIP modulation of immune cell functions.

  1996cites this paper
• Functional and molecular characterization of VIP receptors and signal transduction in human and rodent immune systems.

  1996cites this paper
• Differential expression of vasoactive intestinal peptide receptors 1 and 2 (VIP-R1 and VIP-R2) mRNA in murine lymphocytes.

  1996cites this paper
• Characterization of adenylyl cyclase stimulated by VIP in rat and mouse peritoneal macrophage membranes.

  1996cites this paper
• Regulatory effects of vasoactive intestinal peptide on cytokine production in central and peripheral lymphoid organs.

  1996cites this paper
• Haloperidol and spiperone potentiate murine splenic B cell proliferation.

  1996cites this paper
• Neuropeptides as regulators of airway function: vasoactive intestinal peptide and the tachykinins.

  1995cites this paper
• Neuropeptide Regulation of Cytokine Expression: Effects of VIP and Ro 25–1553

  1995cites this paper
• Neuropeptides as native immune modulators.

  1995cites this paper
• Pituitary adenylate cyclase-activating polypeptides ( PACAP27 and PACAP38) inhibit the mobility of murine thymocytes and splenic lymphocytes: comparison with VIP and implication of cAMP

  1995cites this paper
• Expression of VIP receptors in mouse peritoneal macrophages: functional and molecular characterization.

  1994cites this paper
• Neuroimmunomodulation in the Gastrointestinal Tract

  1994cites this paper
• Vasoactive intestinal peptide modulation of adherence and mobility in rat peritoneal lymphocytes and macrophages.

  1994cites this paper
• Priming effect of vasoactive intestinal peptide on the respiratory burst of neutrophils non-mediated by plasma membrane receptors

  1994cites this paper
• Gene expression of VIP receptor in rat lymphocytes.

  1994cites this paper
• Immunoregulation by Neuropeptides Other than Corticotropin and Melanotropin

  1994cites this paper
• Vasoactive intestinal peptide inhibits fMLP-induced respiratory burst in human lymphocytes.

  1994cites this paper
• Receptor-independent mechanisms are involved in the priming of neutrophil's oxidase by vasoactive intestinal peptide.

  1994cites this paper
• Neuropeptides and Airway-Inflammation

  1993cites this paper
• Inhibitory effects of vasoactive intestinal peptide on superoxide anion formation by N-formyl-methionyl-leucyl-phenylalanine-activated inflammatory cells in vitro.

  1993cites this paper
• Peptidergic Regulation of Mucosal Immune Function

  1993cites this paper
• Chapter 6 – Modulation of Endothelial–Inflammatory Cell Interactions by Primary Afferent Nerves

  1993cites this paper
• Modulation of human natural killer activity by vasoactive intestinal peptide (VIP) family. VIP, glucagon and GHRF specifically inhibit NK activity.

  1992cites this paper
• Vasoactive intestinal peptide stimulates immunoglobulin production and growth of human B cells

  1992cites this paper
• An endothelial cell-line contains functional vasoactive intestinal polypeptide receptors: they control inwardly rectifying K+ channels.

  1992cites this paper
• Vasoactive intestinal peptide: autocrine growth factor in neuroblastoma.

  1992cites this paper
• Occurrence of Vasoactive Intestinal Peptide (VIP) in Lymphoid Organs from Rat and Mouse a

  1992cites this paper
• Somatostatin inhibition of VIP- and isoproterenol-stimulated cyclic AMP production in rat peritoneal macrophages.

  1992cites this paper
• Immunoregulatory role of neuropeptides.

  1992cites this paper
• Neuropeptides and the regulation of granulomatous inflammation.

  1992cites this paper
• Receptors for vasoactive intestinal peptide on murine lymphocytes turn over rapidly.

  1992cites this paper
• Vasoactive intestinal polypeptide (VIP) inhibits rat alveolar macrophage phagocytosis and chemotaxis in vitro.

  1992cites this paper
• Vasoactive intestinal peptide enhances phorbol myristate acetate-induced chemiluminescence in human lymphocytes.

  1992cites this paper
• VIP Restores Natural Killer Cell Activity Depressed by Hepatitis B Surface Antigen

  1992cites this paper
• Vasoactive Intestinal Peptide Receptor Expression on Human Lymphoblasts

  1992cites this paper
• Role of sulfhydryl groups in the binding of vasoactive intestinal peptide to its receptor on murine lymphocytes.

  1992cites this paper
• Modulation by neurotensin and neuromedin N of adherence and chemotaxis capacity of murine lymphocytes.

  1992cites this paper
• Functional and immunological responses of Jurkat lymphocytes transfected with the substance P receptor

  1992cites this paper
• Human intraepithelial lymphocytes

  1991cites this paper
• Production of neuropeptides by inflammatory cells within the granulomas of murine Schistosomiasis mansoni

  1991cites this paper
• Presence of vasoactive intestinal peptide receptors in nasal mucosa.

  1991cites this paper
• Dual effects of vasoactive intestinal peptide (VIP) on leucocyte migration.

  1991cites this paper
• Assays for Vasoactive Intestinal Peptide Receptor

  1991cites this paper
• Modulation of immune function by intestinal neuropeptides.

  1991cites this paper
• Granulomas in murine schistosomiasis mansoni contain vasoactive intestinal peptide-responsive lymphocytes.

  1991cites this paper
• Interactions between neuropeptides and dexamethasone on the mitogenic response of rabbit spleen lymphocytes.

  1991cites this paper
• [Allergy and the endocrine system of the gastrointestinal tract].

  1991cites this paper
• In vivo influences of phorbol ester and calcium ionophore on lymphocyte traffic, lymph flow and efferent lymph levels of thromboxane B2 in sheep.

  1991cites this paper
• Inhibition of mitogen-stimulated proliferation of murine splenocytes by a novel neuropeptide, pituitary adenylate cyclase activating polypeptide: a comparative study with vasoactive intestinal peptide.

  1991cites this paper
• Characterization of functional receptors for vasoactive intestinal peptide (VIP) in rat peritoneal macrophages.

  1991cites this paper
• Effects of prepro-vasoactive intestinal peptide-derived peptides on the murine immune response.

  1990cites this paper
• High affinity specific binding of vasoactive intestinal peptide to human circulating T cells, B cells and large granular lymphocytes.

  1990cites this paper
• Peptide regulation of mast-cell function.

  1990cites this paper
• 31 – Somatostatin: Treatment of Gut Endocrinopathies and a Mechanism of Action

  1990cites this paper
• Acquired immune deficiency syndrome and the developing nervous system.

  1990cites this paper
• Dual effect of vasoactive intestinal peptide on the mitogenic response of rabbit spleen lymphocytes.

  1990cites this paper
• Depression of peripheral lymph node lymphocyte traffic in sheep following central venous allogeneic whole-blood transfusion.

  1990cites this paper
• VIP receptors in human SUP-T1 lymphoblasts.

  1990cites this paper